Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib. (Q54634525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

title

Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

Jonathan C Welti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

author name string

M Gourlaouen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

T Powles

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

S C Kudahetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

P Wilson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

A R Reynolds

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

8 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1183-1193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Molecular basis for sunitinib efficacy and future clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

A quantitative analysis of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

An optimized three-dimensional in vitro model for the analysis of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Resistance to targeted therapy in renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.503

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21057538 AND SRC:MED&resulttype=core&format=json

15 January 2020

1 reference